23.84

2.01% 0.47

시장 영업 전: 23.51 -0.33 -1.38%

Lyell Immunopharma Inc (LYEL)

개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측

Lyell Immunopharma Inc (LYEL) 재무 분석

*모든 숫자는 백만 단위입니다.

기간 종료일	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
기간	3개월	3개월	3개월	3개월	3개월
Revenues	87.50% 0.015	0.008	0.007	0.011	0.034
Operating Expenses	20.96% 37.27	47.15	57.37	201.16	50.54
Benefits Costs and Expenses	-	-	-	-	-
Costs And Expenses	20.96% 37.27	47.15	57.37	201.16	50.54
Operating Income/Loss	20.97% -37.25	-47.14	-57.37	-201.15	-50.51
Nonoperating Income/Loss	135.75% -1.593	4.456	5.172	9.212	5.922
Income/Loss From Continuing Operations Before Tax	87.50% 0.015	0.008	0.007	0.011	0.034
Income/Loss From Continuing Operations After Tax	8.99% -38.85	-42.68	-52.20	-191.94	-44.58
Net Income/Loss	8.99% -38.85	-42.68	-52.20	-191.94	-44.58
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	23.49% 18.27	14.79	295.10	6.157	256.31
Diluted Average Shares	23.49% 18.27	14.79	295.10	6.157	256.31
Basic Earnings Per Share	26.30% -2.13	-2.89	-0.18	-0.72	-0.17
Diluted Earnings Per Share	26.30% -2.13	-2.89	-0.18	-0.72	-0.17
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

MRNA

$54.26

2.69%

RPRX

$48.70

0.25%

BNTX

$99.47

1.08%

RVMD

$152.54

3.76%

INSM

$146.74

4.34%

ONC

$319.94

3.21%

야후에서 열기 | 구글에서 열기 | 핀비즈에서 열기 | MarketWatch에서 열기 | EDGAR에서 열기 | 로이터에서 공개